Found 0 matching trials
Cannabis Extract in Refractory Epilepsy Study PHASE3 The purpose of this study is to examine whether a low dose of CBD+THC will ...
Show More Location
University Hospital Campus, London Health Sciences Centre
Learn More & Join Trial
Efficacy of SUN N4057 in Subjects With Acute Ischemic Stroke and Measurable Penumbra on Magnetic Resonance Imaging (MRI) PHASE2 This research study is designed to evaluate the safety, tolerability, and e...
Show More Location
UCLA Stroke Network
Learn More & Join Trial
Omega-3/Omega-6 Fatty Acids for Attention-Deficit/Hyperactivity Disorder (ADHD): A Trial in Children and Adolescents PHASE3 Objective: To assess whether supplementation with Omega 3/6 fatty acids (ey...
Show More Location
Multiple Locations
Learn More & Join Trial
Proof-of-concept Study Evaluating Subcutaneous Amlitelimab in Adult Participants With Moderate to Severe Hidradenitis Suppurativa PHASE2 This is a parallel, Phase 2, 2-arm, double-blind, randomized, multicenter, ...
Show More Location
Medical Dermatology Specialists Site Number : 8400002
Learn More & Join Trial
Mucolytic Effectiveness of Tacholiquine ® in Chronic Bronchitis PHASE4 The purpose of this study is to evaluate the mucolytic activity of Tacholiq...
Show More Learn More & Join Trial
A Phase 1 Study of PROT-001. PHASE1 A Phase 1, First-In-Human, Randomized, Double-Blind, Placebo-Controlled Mul...
Show More Location
Nucleus Network Pty Ltd
Learn More & Join Trial
BI 443651 Methacholine Challenge PHASE1 The primary objective of this study is to investigate safety and tolerabili...
Show More Location
The Medicines Evaluation Unit
Learn More & Join Trial
Sitagliptin Mechanism of Action Study in Patients With Type 2 Diabetes Mellitus (0431-059) PHASE1 A clinical study to determine the safety, efficacy and the way sitagliptin ...
Show More Location
Multiple Locations
Learn More & Join Trial
Behavioral and Subjective Efficacy of Ramelteon in Subjects With a History of Polydrug Abuse PHASE2 The purpose of this study is to determine the relative abuse potential of r...
Show More Location
Multiple Locations
Learn More & Join Trial
A Phase 2b Study of Baricitinib in Participants With Moderate to Severe Psoriasis PHASE2 This is a dose-ranging study designed to investigate the efficacy and safet...
Show More Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Learn More & Join Trial